Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zero Tariff On Anticancer Drugs To China, Will MNCs Sing Hymn?

Executive Summary

Commonly-prescribed medicines, especially imported anticancer drugs, will potentially see zero tariffs in China, although this may be a symbolic sign rather than a substantive move to improve market access for highly-priced products, some say.


Related Content

China Zero Tariffs For Cancer Drugs Precede High-Stakes Trade Talks
China Vs Cancer: An Infographic Snapshot
China Talks Up AI, Big Data, Cancer Care But Approval, Coverage Huddles Persist





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts